Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7285)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2016 (publication date) through Jan 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yi R, Li Y, Wang FL, Miao G, Qi RM, Zhao YY. MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer. World J Gastrointest Oncol 2016; 8(4): 330-340 [PMID: 27096028 DOI: 10.4251/wjgo.v8.i4.330] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v8/i4/330.htm |
| Number | Citing Articles |
| 1 |
Madhav Madurantakam Royam, Chellan Kumarasamy, Siddhartha Baxi, Ajay Gupta, Nachimuthu Ramesh, Gothandam Kodiveri Muthukaliannan, Rama Jayaraj. Current Evidence on miRNAs as Potential Theranostic Markers for Detecting Chemoresistance in Colorectal Cancer: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies. Molecular Diagnosis & Therapy 2019; 23(1): 65 doi: 10.1007/s40291-019-00381-6
|
| 2 |
Lula Smith, Samuel Anti, Natalie White, Sabita N. Saldanha. Epigenetic Mechanisms in Cancer. 2018; : 87 doi: 10.1016/B978-0-12-809552-2.00004-8
|
| 3 |
Rui Wei, Lei Chen, Da Qin, Qingdong Guo, Shengtao Zhu, Peng Li, Li Min, Shutian Zhang. Liquid Biopsy of Extracellular Vesicle-Derived miR-193a-5p in Colorectal Cancer and Discovery of Its Tumor-Suppressor Functions. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01372
|
| 4 |
Reihaneh Rafiee, Ehsan Razmara, Mahsa Motavaf, Majid Mossahebi-Mohammadi, Shima Khajehsharifi, Fatemeh Rouhollah, Sadegh Babashah. Circulating serum miR-1246 and miR-1229 as diagnostic biomarkers in colorectal carcinoma. Journal of Cancer Research and Therapeutics 2022; 18(Suppl 2): S383 doi: 10.4103/jcrt.JCRT_752_20
|
| 5 |
Klara Cervena, Vendula Novosadova, Barbara Pardini, Alessio Naccarati, Alena Opattova, Josef Horak, Sona Vodenkova, Tomas Buchler, Pavel Skrobanek, Miroslav Levy, Pavel Vodicka, Veronika Vymetalkova. Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.702258
|
| 6 |
Juan Xing, Yiqun Liao, Huan Zhang, Wenjie Zhang, Zhilin Zhang, Jie Zhang, Daorong Wang, Dong Tang. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.804689
|
| 7 |
|
| 8 |
Sahand Moazzendizaji, Andrey Sevbitov, Fatemeh Ezzatifar, Hamid Reza Jalili, Morteza Aalii, Maryam Hemmatzadeh, Saeed Aslani, Jamshid Gholizadeh Navashenaq, Roghaiyeh Safari, Ramin Hosseinzadeh, Mohammad Reza Rahmany, Hamed Mohammadi. microRNAs: Small molecules with a large impact on colorectal cancer. Biotechnology and Applied Biochemistry 2022; 69(5): 1893 doi: 10.1002/bab.2255
|
| 9 |
Elmira Gheytanchi, Fatemeh Tajik, Mahdieh Razmi, Sadegh Babashah, William Chi Shing Cho, Kiarash Tanha, Maryam Sahlolbei, Roya Ghods, Zahra Madjd. Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02851-8
|
| 10 |
Jiupeng Zhou, Hui Guo, Yuanli Yang, Yongfeng Zhang, Heng Liu. A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients. Medicine 2019; 98(16): e15335 doi: 10.1097/MD.0000000000015335
|
| 11 |
Shu Chen, Yang Wang, Chunxia Ni, Ge Meng, Xiaofang Sheng. HLF/miR-132/TTK axis regulates cell proliferation, metastasis and radiosensitivity of glioma cells. Biomedicine & Pharmacotherapy 2016; 83: 898 doi: 10.1016/j.biopha.2016.08.004
|
| 12 |
Jianjie Zhao, Zhirong Li, Yi Chen, Shu Zhang, Lingji Guo, Bo Gao, Yan Jiang, Wuguo Tian, Shuai Hao, Xiaohua Zhang. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4615
|
| 13 |
Jinqiu Wang, Yang Lu, Yiyong Zeng, Leming Zhang, Kongliang Ke, Yu Guo. Expression profile and biological function of miR‑455‑5p in colorectal carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9862
|
| 14 |
María Antonia Lizarbe, Jorge Calle-Espinosa, Eva Fernández-Lizarbe, Sara Fernández-Lizarbe, Miguel Ángel Robles, Nieves Olmo, Javier Turnay. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/7354260
|
| 15 |
Cheng Pan, Xuebing Yan, Hao Li, Linsheng Huang, Mingming Yin, Yongzhi Yang, Renyuan Gao, Leiming Hong, Yanlei Ma, Chenzhang Shi, Huanlong Qin, Peng Zhang. Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer. Oncotarget 2017; 8(40): 68317 doi: 10.18632/oncotarget.19344
|
| 16 |
Qiwen Shi, Anupam Bishayee, Deepak Bhatia. Epigenetics of Cancer Prevention. 2019; : 3 doi: 10.1016/B978-0-12-812494-9.00001-9
|
| 17 |
Zhiwen Huang, Wei Lei, Hai‐Bo Hu, Hongyan Zhang, Yehan Zhu. H19 promotes non‐small‐cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR‐17. Journal of Cellular Physiology 2018; 233(10): 6768 doi: 10.1002/jcp.26530
|
| 18 |
Deming Ou, Ying Wu, Jun Liu, Xiaomei Lao, Sien Zhang, Guiqing Liao. miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin. Oncology Letters 2016; 12(4): 2531 doi: 10.3892/ol.2016.4938
|
| 19 |
Yongqin Pan, Genlong Jiao, Cunchuan Wang, Jingge Yang, Wah Yang. MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1. Biomedicine & Pharmacotherapy 2016; 83: 1398 doi: 10.1016/j.biopha.2016.08.058
|
| 20 |
L. Wang, Y. Mou, D. Meng, Y. Sun, X. Chen, X. Yang, C. Jia, X. Song, X. Li. MicroRNA‐203 inhibits tumour growth and metastasis through PDPN. Clinical Otolaryngology 2017; 42(3): 620 doi: 10.1111/coa.12785
|
| 21 |
Mitsuo Tsukamoto, Hisae Iinuma, Takahiro Yagi, Keiji Matsuda, Yojiro Hashiguchi. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Oncology 2017; 92(6): 360 doi: 10.1159/000463387
|
| 22 |
Laura Gavrilas, Corina Ionescu, Oana Tudoran, Cosmin Lisencu, Ovidiu Balacescu, Doina Miere. The Role of Bioactive Dietary Components in Modulating miRNA Expression in Colorectal Cancer. Nutrients 2016; 8(10): 590 doi: 10.3390/nu8100590
|
| 23 |
Alireza Ahadi. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent. Non-coding RNA Research 2020; 5(3): 125 doi: 10.1016/j.ncrna.2020.08.003
|
| 24 |
Montaser Bellah Yasser, Mahmoud Abdellatif, Esraa Emad, Afnan Jafer, Samar Ahmed, Lobna Nageb, Hanan Abdelshafy, Amany Mohamed Al-Anany, Mohamed Ali Ezz Al-Arab, Abdullah Ahmed Gibriel. Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma. Virus Research 2021; 296: 198341 doi: 10.1016/j.virusres.2021.198341
|
| 25 |
Yudith Annisa Ayu Rezkitha, Nur Syahadati Retno Panenggak, Maria Inge Lusida, Raissa Virgy Rianda, Isna Mahmudah, Aditya Doni Pradana, Tomohisa Uchida, Muhammad Miftahussurur. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis. Journal of Medicine and Life 2024; 17(1): 4 doi: 10.25122/jml-2023-0269
|
| 26 |
Jian Shen, Minzhe Li. MicroRNA-744 Inhibits Cellular Proliferation and Invasion of Colorectal Cancer by Directly Targeting Oncogene Notch1. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(9): 1401 doi: 10.3727/096504018X15188747585738
|
| 27 |
Rosa Hernández, Ester Sánchez-Jiménez, Consolación Melguizo, Jose Prados, Ana Rosa Rama. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives. BMB Reports 2018; 51(11): 563 doi: 10.5483/BMBRep.2018.51.11.116
|
| 28 |
Zhili Cao, Xiang Zheng, Lei Cao, Naixin Liang. [ARTICLE WITHDRAWN] MicroRNA-539 Inhibits the Epithelial‐Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(4): 529 doi: 10.3727/096504017X14972679378357
|
| 29 |
H�ctor Ardila, Mar�a Sanabria‑Salas, Ximena Meneses, Rafael Rios, Antonio Huertas‑Salgado, Martha Serrano. Circulating miR‑141‑3p, miR‑143‑3p and miR‑200c‑3p are differentially expressed in colorectal cancer and advanced adenomas. Molecular and Clinical Oncology 2019; doi: 10.3892/mco.2019.1876
|
| 30 |
Yukihiro Yoshikawa, Mitsuko Fukunaga, Junichi Takahashi, Dai Shimizu, Takaaki Masuda, Tsunekazu Mizushima, Kazutaka Yamada, Masaki Mori, Hidetoshi Eguchi, Yuichiro Doki, Takahiro Ochiya, Koshi Mimori. Identification of the Minimum Combination of Serum microRNAs to Predict the Recurrence of Colorectal Cancer Cases. Annals of Surgical Oncology 2023; 30(1): 233 doi: 10.1245/s10434-022-12355-w
|
| 31 |
Xiangxiang Liu, Bei Pan, Li Sun, Xiaoxiang Chen, Kaixuan Zeng, Xiuxiu Hu, Tao Xu, Mu Xu, Shukui Wang. Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention 2018; 27(7): 746 doi: 10.1158/1055-9965.EPI-18-0067
|
| 32 |
Allan Fellizar, Vivencio Refuerzo, John Donnie Ramos, Pia Marie Albano. Expression of specific microRNAs in tissue and plasma in colorectal cancer. Journal of Pathology and Translational Medicine 2023; 57(3): 147 doi: 10.4132/jptm.2022.02.19
|